This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dorsman, J. C. Articles by van der Eb, A. J. Search for Related Content PubMed PubMed Citation Articles by Dorsman, J. C. Articles by van der Eb, A. J.

 Previous Article  |  Next Article 

J. Virol., May 1995, 2962-2967, Vol 69, No. 5
Copyright © 1995, American Society for Microbiology

The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains

JC Dorsman, BM Hagmeyer, J Veenstra, P Elfferich, N Nabben, A Zantema and AJ van der Eb
Department of Medical Biochemistry, Sylvius Laboratory, Leiden, The Netherlands.

The transforming E1A 12S and E1A 13S proteins of human adenovirus type 5 (Ad5) contain two and three conserved regions, respectively. In the present study, the contribution of sequences in the nonconserved N- terminal region of the E1A proteins to morphological transformation and to down-regulation of a number of mitogen-inducible genes was investigated. As described previously, transformation of NRK cells (an established normal rat kidney cell line) results in denser cell growth and a cuboidal cellular morphology. None of the cells expressing N- terminally mutated E1A proteins, however, show these transformed properties, which suggests an important role for sequences in that domain. The decrease in cyclin D1 levels requires exactly the same sequences. The ability to transform NRK cells and to reduce cyclin D1 levels does not correlate with the presence in the E1A proteins of binding domains for p300, CBP, p107, pRb, cyclin A, or cdk2. In contrast, down-regulation of expression of the JE gene in NRK cells and repression of transcription of the collagenase gene in human HeLa cells does correlate with the presence in the E1A proteins of an intact binding domain for p300 and CBP. The results suggest that the N- terminal domain of the E1A proteins can repress expression of cellular genes by at least two different mechanisms.

This article has been cited by other articles:

• Soeth, E., Thurber, D. B., Smith, C. L. (2002). The Viral Transactivator E1A Regulates the Mouse Mammary Tumor Virus Promoter in an Isoform- and Chromatin-specific Manner. J. Biol. Chem. 277: 19847-19854 [Abstract] [Full Text]  
• Keblusek, P, Dorsman, J., Teunisse, A., Teunissen, H, van der Eb, A., Zantema, A (1999). The adenoviral E1A oncoproteins interfere with the growth-inhibiting effect of the cdk-inhibitor p21(CIP1/WAF1). J. Gen. Virol. 80: 381-390 [Abstract]  
• Facchini, L., Penn, L. Z. (1998). The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12: 633-651 [Abstract] [Full Text]  
• Bishopric, N. H., Zeng, G.-Q., Sato, B., Webster, K. A. (1997). Adenovirus E1A Inhibits Cardiac Myocyte-specific Gene Expression through Its Amino Terminus. J. Biol. Chem. 272: 20584-20594 [Abstract] [Full Text]  
• Cook, J. L., Krantz, C. K., Routes, B. A. (1996). Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell rejection. Proc. Natl. Acad. Sci. USA 93: 13985-13990 [Abstract] [Full Text]